Skip to main content

Reimbursement

13
Aug 2025

Positive HAS opinion for regular reimbursement of NGS panels in two indications in France

On July 29, 2025, the French National Authority for Health (HAS) issued positive opinions on including targeted next-generation sequencing-based panels in certain clinical indications for patients with aminoacidopathy and acute leukaemia in the NABM Nomenclature for regular reimbursement. Currently, these tests are temporarily reimbursed within the innovative payment scheme (RIHN). These HAS assessments are performed by HAS as a part of the RIHN reform and ‘cleaning up’ the List of temporary covered tests.
05
Aug 2025

July 2025 recommendations about add-on reimbursement for medical devices in France

The French National Authority for Health (HAS) released new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the July 2025 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Four favourable opinions were issued concerning add-on reimbursement for medical devices in the orthopedics and ENT fields.
01
Aug 2025

A new coverage with evidence development scheme was announced in the Netherlands

In July 2025, the Dutch Healthcare Institute (ZIN) announced a new policy framework “Reimbursement within Research” (Vergoeding in Onderzoek), which allows temporary reimbursement under basic health insurance during the evaluation period for specialist medical care and medical devices with limited evidence of effectiveness. ZIN is currently reviewing the framework to provide advice on implementation. The launch of the new framework is expected in November 2025.
28
Jul 2025

New Med Tech-related HTAs to support reimbursement decision-making in Austria

On July 15, 2025, the Austrian Institute for HTA (AIHTA) published four new HTAs (decision support documents) and two updates to previous decision support documents that provide recommendations regarding possible inclusion of new procedures in the reimbursement catalog of individual medical services (MEL). The assessments concerned cardiovascular, gastrointestinal, interventional radiology, men's health, urology, and orthopedics fields.
21
Jul 2025

Pre-launch adjustments were requested to the new outpatient tariff system in Switzerland

The new Swiss outpatient billing system, comprising the TARDOC catalog of individual service tariffs and outpatient flat rates, approved by the Federal Council, is expected to take effect on January 1, 2026. On July 15, 2025, the Organization for Outpatient Physician Tariffs (OAAT AG) requested pre-launch adjustments to this system concerning hospital emergency and non-physician services, combination therapy in cancer treatment, wound care, and pathology services.
09
Jul 2025

New Nomenclature Articles introduced for orthopedic technologists in July 2025 in Belgium

On July 1, 2025, the National Institute for Health and Disability Insurance (INAMI/RIZIV) updated Nomenclature to recognize the new professional title "orthopedic technologist", replacing the former specialties of "bandaging specialist" and "orthotist". Two Articles were repealed, and three new Articles have been introduced, detailing reimbursement for services in bandagery, orthotics, prosthetics, and orthopedic footwear services.
08
Jul 2025

The revised EBM catalog for the third quarter of 2025 published in Germany

On July 1, 2025, the revised EBM (German Uniform Evaluation Standard) catalog for the third quarter of 2025 came into force. The main changes introduced concern updates of the contents (services legends, preambles of several EBM subchapters) and the introduction of new EBM codes for the reimbursement of transmitters for telemonitoring and telemedical monitoring of implantable cardiac devices, as well as codes for the services provided within the co-funded study on low-dose pulsed ultrasound for pseudarthrosis.
01
Jul 2025

June 2025 recommendations about add-on reimbursement for medical devices in France

The French National Authority for Health (HAS) released new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the June 2025 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Seven favourable opinions were issued concerning add-on reimbursement for medical devices in the cardiovascular, peripheral vascular, and ophthalmology fields.
18
Jun 2025

Advice on criteria for inclusion of technologies into the basic health insurance in the Netherlands

In May 2025, the Dutch Healthcare Institute (ZIN) published the Advice on considering staff deployment and sustainability criteria when assessing whether to reimburse medical procedures and technologies from basic health insurance. Since May 2025, ZIN has initiated a three-year trial to incorporate these criteria into the assessment process, with an interim evaluation after 1.5 years to be discussed with the Ministry of Health, Welfare, and Sport.